CDC Supports Microbiome Science, New Publications

Read the latest research on the human microbiome, a promising frontier for public health

CDC Supports Microbiome Science to Advance Infection Prevention,  Clinical Care, and Public Health

Controlling and containing emerging antibiotic-resistant threats and protecting people requires novel and innovative approaches. The human microbiome is a promising area of research for these efforts.

Infectious disease experts at the U.S. Centers for Disease Control and Prevention (CDC) and the National Institutes of Health (NIH) recently co-edited a special issue of the Journal of Infectious Diseases featuring 16 review articles on innovative research of the human microbiome. The microbiome is the community of naturally occurring microorganisms in and on our bodies. This work represents ongoing engagement and financial support from CDC’s Antibiotic Resistance (AR) Solutions Initiative to leverage the microbiome for new ways to prevent antibiotic-resistant infections.

The journal supplement highlights the latest research and significant promise the human microbiome holds for addressing public health challenges, also discussed in a recent Safe Healthcare Blog post. Topic areas range from sepsis, Clostridioides difficile, and necrotizing enterocolitis, to the vaginal, gut, and lung microbiomes. CDC experts see opportunities for microbiome-based solutions to restore gut health (where many opportunistic microorganism reside), predict disease severity, and mitigate or cure infections.  There is more to learn about the human microbiome. Antibiotics can disrupt a healthy microbiome, and through microbiome research we are learning how to tailor antibiotic treatment and prevention methods to a patient’s individual microbiome.  CDC is committed to furthering microbiome science for public health and calls on academia, industry, and practitioners to help push the current science toward practicable prevention and mitigation strategies that protect people from infectious diseases and antibiotic-resistant pathogens.  Read more about how CDC’s AR Solutions Initiative invests in innovative antibiotic resistance research.

Centers for Disease Control and Prevention 1600 Clifton Rd   Atlanta, GA 30329   1-800-CDC-INFO (800-232-4636)   TTY: 888-232-6348 Questions or Problems  |  Unsubscribe